Systemic Therapy De-Escalation in Early-Stage Triple-Negative Breast Cancer: Dawn of a New Era?

Early-stage triple negative breast cancer (TNBC) has been traditionally treated with surgery, radiation, and chemotherapy. The current standard of care systemic treatment of early-stage II and III TNBC involves the use of anthracycline-cyclophosphamide and carboplatin-paclitaxel with pembrolizumab i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ravi Kumar Gupta, Arya Mariam Roy, Ashish Gupta, Kazuaki Takabe, Ajay Dhakal, Mateusz Opyrchal, Pawel Kalinski, Shipra Gandhi
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2022-04-01
Colecção:Cancers
Assuntos:
triple-negative breast cancer
de-escalation
targeted therapy
BRCA mutations
chemotherapy
neo adjuvant treatment
Acesso em linha:https://www.mdpi.com/2072-6694/14/8/1856
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados